PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.95%
Positive revenue growth while QCOM is negative. John Neff might see a notable competitive edge here.
6.95%
Positive gross profit growth while QCOM is negative. John Neff would see a clear operational edge over the competitor.
-383.16%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-383.16%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
90.00%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
100.00%
Positive EPS growth while QCOM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
100.00%
Positive diluted EPS growth while QCOM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.51%
Slight or no buybacks while QCOM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.51%
Slight or no buyback while QCOM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
100.00%
Dividend growth above 1.5x QCOM's 4.33%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.74%
10Y revenue/share CAGR under 50% of QCOM's 161.71%. Michael Burry would suspect a lasting competitive disadvantage.
8.74%
5Y revenue/share CAGR under 50% of QCOM's 118.62%. Michael Burry would suspect a significant competitive gap or product weakness.
8.74%
Positive 3Y CAGR while QCOM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
163.69%
Net income/share CAGR at 50-75% of QCOM's 231.57%. Martin Whitman might question if the firm’s product or cost base lags behind.
163.69%
5Y net income/share CAGR at 50-75% of QCOM's 225.62%. Martin Whitman might see a shortfall in operational efficiency or brand power.
163.69%
Positive short-term CAGR while QCOM is negative. John Neff would see a clear advantage in near-term profit trajectory.
19.04%
10Y equity/share CAGR in line with QCOM's 20.67%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
19.04%
Below 50% of QCOM's 749.40%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.04%
Below 50% of QCOM's 74.21%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.